Outsourced Drug Discovery Market by Drug Type (Small Molecule Drugs and Large Molecule Drugs), by Services (Preclinical Developments, Target validation and Functional Informatics, Target Identification and Screening, Lead Identification and Candidate Opti

Outsourced Drug Discovery Market by Drug Type (Small Molecule Drugs and Large Molecule Drugs), by Services (Preclinical Developments, Target validation and Functional Informatics, Target Identification and Screening, Lead Identification and Candidate Optimization, and Others), by Application (Oncology, Ophthalmology, Hematology, Immunomodulation, Anti-Infective Drugs, Dermatology, Neurology, Cardiology, and Others), by End Users (Pharmaceutical and Biotechnological Companies, Contract research Organization, and Contract Manufacturing Organization), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast, 2022 - 2028

Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development.
Market Dynamics
New strategies adopted by key players related to outsourcing drug discovery is expected to drive growth of global outsourced drug discovery market. For instance, in June 2019, GlaxoSmithKline (GSK), a British drug manufacturing company collaborated with the University of California to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research (LGR), in San Francisco. The new laboratory will investigate how gene mutations cause diseases, and also develop new technologies using CRISPR to rapidly accelerate the discovery of new medicines.
Furthermore, extension of partnership activities is expected to propel global outsourced drug discovery market growth. For instance, in March 2021, Charles River Laboratories (CRL) extended its partnership with Chiesi Farmaceutici. Under this partnership, Charles River Laboratories (CRL) extended its longstanding, strategic, integrated drug discovery program (Respiratory Program). The respiratory program is related to the preclinical drug development for treatment of respiratory diseases and rare diseases.
Key features of the study:
This report provides in-depth analysis of the outsourced drug discovery market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global outsourced drug discovery market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, Aurigene Accelerating Discovery, Bioduro LLC, Charles River Laboratories (CRL), Chempartner, TCG Lifesciences, Evotec AG, Syngene International Ltd. Jubilant Biosys Ltd, Pharmaron Inc., Shanghai Medicilon, and Sundia Meditech Co. Ltd.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global outsourced drug discovery market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for anesthesia device market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:
Global Outsourced Drug Discovery Market, By Drug Type:
Small Molecule Drugs
Large Molecule Drugs
Global Outsourced Drug Discovery market, By Services:
Preclinical Development
Target Validation and Functional Informatics
Target Identification and Screening
Lead Identification and Candidate Optimization
Others
Global Outsourced Drug Discovery Market, By Application
Oncology
Ophthalmology
Hematology
Immunomodulation
Anti-Infective Drugs
Dermatology
Pulmonology
Cardiology
Others
Global Outsourced Drug Discovery market, By End User
Pharmaceutical and Biotechnological Companies
Contract Research Organization
Contract Manufacturing Organization
Global Outsourced Drug Discovery market, By Region:
North America
By Country:
U.S.
Canada
By Drug Type:
Small Molecule Drugs
Large Molecule Drugs
By Services:
Preclinical Development
Target Validation and Functional Informatics
Target Identification and Screening
Lead Identification and Candidate Optimization
Others
By Application
Oncology
Ophthalmology
Hematology
Immunomodulation
Anti-Infective Drugs
Dermatology
Pulmonology
Cardiology
Others
By End User
Pharmaceutical and Biotechnological Companies
Contract Research Organization
Contract Manufacturing Organization
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Drug Type:
Small Molecule Drugs
Large Molecule Drugs
By Services:
Preclinical Development
Target Validation and Functional Informatics
Target Identification and Screening
Lead Identification and Candidate Optimization
Others
By Application
Oncology
Ophthalmology
Hematology
Immunomodulation
Anti-Infective Drugs
Dermatology
Pulmonology
Cardiology
Others
By End User
Pharmaceutical and Biotechnological Companies
Contract Research Organization
Contract Manufacturing Organization
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Drug Type:
Small Molecule Drugs
Large Molecule Drugs
By Services:
Preclinical Development
Target Validation and Functional Informatics
Target Identification and Screening
Lead Identification and Candidate Optimization
Others
By Application
Oncology
Ophthalmology
Hematology
Immunomodulation
Anti-Infective Drugs
Dermatology
Pulmonology
Cardiology
Others
By End User
Pharmaceutical and Biotechnological Companies
Contract Research Organization
Contract Manufacturing Organization
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Drug Type:
Small Molecule Drugs
Large Molecule Drugs
By Services:
Preclinical Development
Target Validation and Functional Informatics
Target Identification and Screening
Lead Identification and Candidate Optimization
Others
By Application
Oncology
Ophthalmology
Hematology
Immunomodulation
Anti-Infective Drugs
Dermatology
Pulmonology
Cardiology
Others
By End User
Pharmaceutical and Biotechnological Companies
Contract Research Organization
Contract Manufacturing Organization
Middle East
By Country/Region:
GCC
Israel
Rest of Middle East
By Drug Type:
Small Molecule Drugs
Large Molecule Drugs
By Services:
Preclinical Development
Target Validation and Functional Informatics
Target Identification and Screening
Lead Identification and Candidate Optimization
Others
By Application
Oncology
Ophthalmology
Hematology
Immunomodulation
Anti-Infective Drugs
Dermatology
Pulmonology
Cardiology
Others
By End User
Pharmaceutical and Biotechnological Companies
Contract Research Organization
Contract Manufacturing Organization
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Drug Type:
Small Molecule Drugs
Large Molecule Drugs
By Services:
Preclinical Development
Target Validation and Functional Informatics
Target Identification and Screening
Lead Identification and Candidate Optimization
Others
By Application
Oncology
Ophthalmology
Hematology
Immunomodulation
Anti-Infective Drugs
Dermatology
Pulmonology
Cardiology
Others
By End User
Pharmaceutical and Biotechnological Companies
Contract Research Organization
Contract Manufacturing Organization
Company Profiles
Aurigene Accelerating Discovery,*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Bioduro LLC.
Charles River Laboratories (CRL)
TCG Lifesciences
Evotec AG
Syngene International Ltd.
Jubilant Biosys Ltd.
Pharmaron Inc.
Shanghai Medicilon Inc.
Sundia Meditech Co. Ltd.
“*” marked represents similar segmentation in other categories in the respective section.